Targeted drug delivery is one of the attractive ways in which cancer treatment can
significantly reduce side effects. In the last two decades, the use of antibodies as a tool for …

Simple Summary This review summarizes recent advances in the nuclear medicine
theranostic approach. It covers the repurposing of historical radiotracers for new indications …

Purpose The upregulation of fibroblast activation protein (FAP) expression has been
observed in various cancers, including metastatic breast carcinoma, prompting research into …

Because of their rapid tumor accumulation and normal tissue clearance, single-domain
antibody fragments (sdAbs) are an attractive vehicle for developing radiotherapeutics …

Single-domain antibody (sdAb) is among the most promising vectors for developing
molecular imaging tracers. Several sdAb tracers targeting human epidermal growth factor …

Single-domain antibody fragments (sdAbs) are attractive for targeted α-particle therapy,
particularly with 211At, because of their rapid accumulation in tumor and clearance from …

Simple Summary With around 15 kD molecular weight, VHHs are considered the smallest
antigen-binding fragments. Based on their unique properties, VHHs have broad application …

Radiolabeled antibodies have become indispensable tools in nuclear medicine. However,
the natural roles of antibodies within the immune system mean that they have several …

Data show a decrease in the risk of hospitalization and death from COVID-19. To date,
global vaccinations for SARS-CoV-2 protections are underway, but additional treatments are …

Purpose Nanobodies have become promising carriers due to excellent in vivo properties.
Radiopharmaceutical therapy targeting programmed cell death ligand 1 (PD-L1) is an …